Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Progyny, Inc. (PGNY : NSDQ)

• Company Description    Progyny Inc. is a fertility benefits management company. It specializes in fertility and family building benefits solutions. Progyny Inc. is based in New York, United States. Number of Employees: 680

• Price / Volume Information    Yesterday's Closing Price: $22.51 Daily Weekly Monthly 20 Day Moving Average: 878,929 shares Shares Outstanding: 85.98 (millions) Market Capitalization: $1,935.45 (millions) Beta: 1.33 52 Week High: $26.57 52 Week Low: $13.39 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.18% -1.93% 12 Week 3.97% -5.56% Year To Date 30.49% 19.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1359 BROADWAY - NEW YORK,NY 10018 USA ph: 212-888-3124 fax: - investors@progyny.com http://www.progyny.com

• General Corporate Information    Officers Peter Anevski - Chief Executive Officer and Director David Schlanger - Chairman Mark Livingston - Chief Financial Officer Debra Morris - Director Lloyd Dean - Director Peer Information Progyny, Inc. (CHCR) Progyny, Inc. (ESRX) Progyny, Inc. (MYDP) Progyny, Inc. (COR) Progyny, Inc. (GBCS) Progyny, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 74340E103 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 85.98 Most Recent Split Date: (:1) Beta: 1.33 Market Capitalization: $1,935.45 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.74 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 16.64% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: 30.63 Trailing 12 Months: 40.93 PEG Ratio: 1.84 Price Ratios Price/Book: 3.75 Price/Cash Flow: 65.23 Price / Sales: 1.56 EPS Growth vs. Year Ago Period: 11.76% vs. Previous Quarter: 11.76% Sales Growth vs. Year Ago Period: 9.47% vs. Previous Quarter: 2.73% ROE 06/30/25 - 10.69 03/31/25 - 10.90 12/31/24 - 10.68 ROA 06/30/25 - 7.12 03/31/25 - 7.20 12/31/24 - 7.30 Current Ratio 06/30/25 - 2.70 03/31/25 - 2.39 12/31/24 - 2.80 Quick Ratio 06/30/25 - 2.70 03/31/25 - 2.39 12/31/24 - 2.80 Operating Margin 06/30/25 - 3.96 03/31/25 - 4.00 12/31/24 - 4.31 Net Margin 06/30/25 - 4.28 03/31/25 - 4.33 12/31/24 - 4.66 Pre-Tax Margin 06/30/25 - 7.18 03/31/25 - 7.19 12/31/24 - 7.13 Book Value 06/30/25 - 6.01 03/31/25 - 5.45 12/31/24 - 4.96 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©